Neutropenia in patients under treatment with clozapine and COVID-19 infection

Introduction Clozapine is among the most effective antipsychotics used for treatment resistant schizophrenia. Adverse reactions to clozapine include neutropenia. Case series report that clozapine-treated patients with COVID-19 have no documented neutropenia. Objectives We sought to investigate t...

Full description

Bibliographic Details

Published in:	European Psychiatry
Main Authors:	S. Bonaccorso, A. Ricciardi, S. Ouabbou, C. Theleritis, A. Ross-Michaelides, A. Metastasio, N. Stewart, M. Mohammed, F. Schifano
Format:	Article
Language:	English
Published:	Cambridge University Press 2021-04-01
Subjects:	clozapine COVID-19 neutropenia schizophrénia
Online Access:	https://www.cambridge.org/core/product/identifier/S092493382101796X/type/journal_article